Timboligue, Bernadette M.

HRN: 28-56-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
CEFTRIAXONE 1G (VIAL)
02/28/2026
03/06/2026
IV
2g
OD
Intraabdominal Infection
Checking Initial Appropriateness 
03/03/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/03/2026
03/10/2026
IV
4.5g
Q8
Cholecystitis, Renal Parenchymal Disease
Checking Initial Appropriateness 
03/06/2026
COTRIMOXAZOLE 960MG (TAB)
03/06/2026
03/13/2026
ORAL
960mg
OD
Prophylaxis
Remove - Pending Acceptance
03/10/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/10/2026
03/17/2026
IV
100mg
OD
Oral Candidiasis
Checking Initial Appropriateness 
03/11/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/11/2026
03/18/2026
ORAL
3cc
BID
Oral Candidiasis
Checking Initial Appropriateness 
03/20/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/20/2026
03/26/2026
ORAL
3cc
TID
Oral Candidiasis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: